Metabolism, Excretion, and Mass Balance of [(14)C]-Rezafungin in Animals and Humans

Rezafungin is a novel echinocandin being developed for treatment of candidemia and invasive candidiasis and for prevention of invasive fungal disease caused by Candida, Aspergillus, and Pneumocystis spp. in recipients of blood and marrow transplantation. Studies using [(14)C]-radiolabeled rezafungin...

Descripción completa

Detalles Bibliográficos
Autores principales: Ong, Voon, Wills, Sarah, Watson, Deborah, Sandison, Taylor, Flanagan, Shawn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2022
Materias:
Clinical Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8765310/
https://www.ncbi.nlm.nih.gov/pubmed/34662192
http://dx.doi.org/10.1128/AAC.01390-21

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8765310/
https://www.ncbi.nlm.nih.gov/pubmed/34662192
http://dx.doi.org/10.1128/AAC.01390-21

Ejemplares similares